Sophocarpidine (CAS 519-02-8) Market Report

China Sophocarpidine (CAS 519-02-8) Industry Market Research Report 2023-2029

  • POSTDATE：Oct 07, 2023
  • PAGES：192
  • REPORT CODE：GMM1833982
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Sophocarpidine is a white acicular crystal or crystalline powder with bitter taste. It is the main raw material for the production of oxymatrine and widely used in the treatment of liver diseases.

    This report elaborates on the current development of the Sophocarpidine (CAS 519-02-8) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Qinghai Lake Pharmaceuticals

    • Selco Wirkstoffe Vertriebs GmbH

    • Select Botanical

    • Jiangsu Tiansheng Pharmaceutical

    • Indena

    • Fujie Pharmaceutical

    • TIANSHAN Pharmaceuticals

    • Tiansheng Pharmaceutical

    By Type:

    • Low Purity

    • High Purity

    By Application:

    • Others

    • Pesticides

    • Pharmaceuticals

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Sophocarpidine (CAS 519-02-8) Market Overview 2018-2029

    • 1.1 China Sophocarpidine (CAS 519-02-8) Industry Development Overview

    • 1.2 China Sophocarpidine (CAS 519-02-8) Industry Development History

    • 1.3 China Sophocarpidine (CAS 519-02-8) Industry Market Size (2018-2029)

    • 1.4 China Sophocarpidine (CAS 519-02-8) Market Analysis by Type from Production Side

      • 1.4.1 China Sophocarpidine (CAS 519-02-8) Production Volume, Production Value and Growth Rate of Low Purity (2018-2029)

      • 1.4.2 China Sophocarpidine (CAS 519-02-8) Production Volume, Production Value and Growth Rate of High Purity (2018-2029)

    • 1.5 China Sophocarpidine (CAS 519-02-8) Market Analysis by Application from Consumption End

      • 1.5.1 China Sophocarpidine (CAS 519-02-8) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.2 China Sophocarpidine (CAS 519-02-8) Sales Volume, Sales Value and Growth Rate of Pesticides (2018-2029)

      • 1.5.3 China Sophocarpidine (CAS 519-02-8) Sales Volume, Sales Value and Growth Rate of Pharmaceuticals (2018-2029)

    • 1.6 China Sophocarpidine (CAS 519-02-8) Market Analysis by Region

      • 1.6.1 North China Sophocarpidine (CAS 519-02-8) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Sophocarpidine (CAS 519-02-8) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Sophocarpidine (CAS 519-02-8) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Sophocarpidine (CAS 519-02-8) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Sophocarpidine (CAS 519-02-8) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Sophocarpidine (CAS 519-02-8) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Sophocarpidine (CAS 519-02-8) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Sophocarpidine (CAS 519-02-8) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Sophocarpidine (CAS 519-02-8) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Sophocarpidine (CAS 519-02-8) Market Status and Competition Analysis in 2023

      • 2.2.3 China Sophocarpidine (CAS 519-02-8) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Sophocarpidine (CAS 519-02-8) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Sophocarpidine (CAS 519-02-8) Industry Development

    Chapter 3 Sophocarpidine (CAS 519-02-8)Industry Chain Analysis

    • 3.1 Sophocarpidine (CAS 519-02-8) Industry Chain

    • 3.2 Sophocarpidine (CAS 519-02-8) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Sophocarpidine (CAS 519-02-8) Market

    • 3.3 Sophocarpidine (CAS 519-02-8) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Sophocarpidine (CAS 519-02-8) Market

    Chapter 4 China Sophocarpidine (CAS 519-02-8) Market, by Type

    • 4.1 China Sophocarpidine (CAS 519-02-8) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Sophocarpidine (CAS 519-02-8) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Sophocarpidine (CAS 519-02-8) Production Volume and Growth Rate, by Type

      • 4.5.1 China Sophocarpidine (CAS 519-02-8) Production Volume and Growth Rate of Low Purity

      • 4.5.2 China Sophocarpidine (CAS 519-02-8) Production Volume and Growth Rate of High Purity

    Chapter 5 China Sophocarpidine (CAS 519-02-8) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Sophocarpidine (CAS 519-02-8) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Sophocarpidine (CAS 519-02-8) Market Size and Growth Rate, by Application

      • 5.5.1 China Sophocarpidine (CAS 519-02-8) Market Size and Growth Rate of Others

      • 5.5.2 China Sophocarpidine (CAS 519-02-8) Market Size and Growth Rate of Pesticides

      • 5.5.3 China Sophocarpidine (CAS 519-02-8) Market Size and Growth Rate of Pharmaceuticals

    Chapter 6 China Sophocarpidine (CAS 519-02-8) Market, by Region

    • 6.1 China Sophocarpidine (CAS 519-02-8) Production Volume and Production Value, by Region

    • 6.2 China Sophocarpidine (CAS 519-02-8) Sales Volume and Sales Value, by Region

    Chapter 7 North China Sophocarpidine (CAS 519-02-8) Market Analysis

    • 7.1 North China Sophocarpidine (CAS 519-02-8) Market, by Type

    • 7.2 North China Sophocarpidine (CAS 519-02-8) Market, by Application

    Chapter 8 Central China Sophocarpidine (CAS 519-02-8) Market Analysis

    • 8.1 Central China Sophocarpidine (CAS 519-02-8) Market, by Type

    • 8.2 Central China Sophocarpidine (CAS 519-02-8) Market, by Application

    Chapter 9 South China Sophocarpidine (CAS 519-02-8) Market Analysis

    • 9.1 South China Sophocarpidine (CAS 519-02-8) Market, by Type

    • 9.2 South China Sophocarpidine (CAS 519-02-8) Market, by Application

    Chapter 10 East China Sophocarpidine (CAS 519-02-8) Market Analysis

    • 10.1 East China Sophocarpidine (CAS 519-02-8) Market, by Type

    • 10.2 East China Sophocarpidine (CAS 519-02-8) Market, by Application

    Chapter 11 Northeast China Sophocarpidine (CAS 519-02-8) Market Analysis

    • 11.1 Northeast China Sophocarpidine (CAS 519-02-8) Market, by Type

    • 11.2 Northeast China Sophocarpidine (CAS 519-02-8) Market, by Application

    Chapter 12 Southwest China Sophocarpidine (CAS 519-02-8) Market Analysis

    • 12.1 Southwest China Sophocarpidine (CAS 519-02-8) Market, by Type

    • 12.2 Southwest China Sophocarpidine (CAS 519-02-8) Market, by Application

    Chapter 13 Northwest China Sophocarpidine (CAS 519-02-8) Market Analysis

    • 13.1 Northwest China Sophocarpidine (CAS 519-02-8) Market, by Type

    • 13.2 Northwest China Sophocarpidine (CAS 519-02-8) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Qinghai Lake Pharmaceuticals

        • 14.1.1 Qinghai Lake Pharmaceuticals Company Profile

        • 14.1.2 Qinghai Lake Pharmaceuticals Sophocarpidine (CAS 519-02-8) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Selco Wirkstoffe Vertriebs GmbH

        • 14.2.1 Selco Wirkstoffe Vertriebs GmbH Company Profile

        • 14.2.2 Selco Wirkstoffe Vertriebs GmbH Sophocarpidine (CAS 519-02-8) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Select Botanical

        • 14.3.1 Select Botanical Company Profile

        • 14.3.2 Select Botanical Sophocarpidine (CAS 519-02-8) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Jiangsu Tiansheng Pharmaceutical

        • 14.4.1 Jiangsu Tiansheng Pharmaceutical Company Profile

        • 14.4.2 Jiangsu Tiansheng Pharmaceutical Sophocarpidine (CAS 519-02-8) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Indena

        • 14.5.1 Indena Company Profile

        • 14.5.2 Indena Sophocarpidine (CAS 519-02-8) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Fujie Pharmaceutical

        • 14.6.1 Fujie Pharmaceutical Company Profile

        • 14.6.2 Fujie Pharmaceutical Sophocarpidine (CAS 519-02-8) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 TIANSHAN Pharmaceuticals

        • 14.7.1 TIANSHAN Pharmaceuticals Company Profile

        • 14.7.2 TIANSHAN Pharmaceuticals Sophocarpidine (CAS 519-02-8) Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Tiansheng Pharmaceutical

        • 14.8.1 Tiansheng Pharmaceutical Company Profile

        • 14.8.2 Tiansheng Pharmaceutical Sophocarpidine (CAS 519-02-8) Market Performance

        • 14.8.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Sophocarpidine (CAS 519-02-8) Industry Research Conclusions

    • 15.2 Sophocarpidine (CAS 519-02-8) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Sophocarpidine (CAS 519-02-8) Industry Market Size (2018-2029)

    • Figure China Sophocarpidine (CAS 519-02-8) Production Volume, Production Value and Growth Rate of Low Purity (2018-2029)

    • Figure China Sophocarpidine (CAS 519-02-8) Production Volume, Production Value and Growth Rate of High Purity (2018-2029)

    • Figure China Sophocarpidine (CAS 519-02-8) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Sophocarpidine (CAS 519-02-8) Sales Volume, Sales Value and Growth Rate of Pesticides (2018-2029)

    • Figure China Sophocarpidine (CAS 519-02-8) Sales Volume, Sales Value and Growth Rate of Pharmaceuticals (2018-2029)

    • Figure North China Sophocarpidine (CAS 519-02-8) Market Size and Growth Rate from 2018-2029

    • Figure Central China Sophocarpidine (CAS 519-02-8) Market Size and Growth Rate from 2018-2029

    • Figure South China Sophocarpidine (CAS 519-02-8) Market Size and Growth Rate from 2018-2029

    • Figure East China Sophocarpidine (CAS 519-02-8) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Sophocarpidine (CAS 519-02-8) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Sophocarpidine (CAS 519-02-8) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Sophocarpidine (CAS 519-02-8) Market Size and Growth Rate from 2018-2029

    • Figure Sophocarpidine (CAS 519-02-8) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Sophocarpidine (CAS 519-02-8) Market Share by Type in 2018

    • Figure China Sophocarpidine (CAS 519-02-8) Market Share by Type in 2023

    • Figure China Sophocarpidine (CAS 519-02-8) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Sophocarpidine (CAS 519-02-8) Production Volume and Growth Rate of Low Purity (2018-2023)

    • Figure China Sophocarpidine (CAS 519-02-8) Production Volume and Growth Rate of High Purity (2018-2023)

    • Figure China Sophocarpidine (CAS 519-02-8) Market Share by Application in 2018

    • Figure China Sophocarpidine (CAS 519-02-8) Market Share by Application in 2023

    • Figure China Sophocarpidine (CAS 519-02-8) Total Market Size and Growth Rate from Consumption End

    • Figure China Sophocarpidine (CAS 519-02-8) Market Size and Growth Rate of Others (2018-2023)

    • Figure China Sophocarpidine (CAS 519-02-8) Market Size and Growth Rate of Pesticides (2018-2023)

    • Figure China Sophocarpidine (CAS 519-02-8) Market Size and Growth Rate of Pharmaceuticals (2018-2023)

    • Table China Sophocarpidine (CAS 519-02-8) Production Volume by Region (2018-2023)

    • Table China Sophocarpidine (CAS 519-02-8) Production Volume Share by Region (2018-2023)

    • Figure China Sophocarpidine (CAS 519-02-8) Production Volume Share by Region (2018-2023)

    • Table China Sophocarpidine (CAS 519-02-8) Production Value by Region (2018-2023)

    • Table China Sophocarpidine (CAS 519-02-8) Production Value Share by Region (2018-2023)

    • Figure China Sophocarpidine (CAS 519-02-8) Production Value Share by Region (2018-2023)

    • Table China Sophocarpidine (CAS 519-02-8) Sales Volume by Region (2018-2023)

    • Table China Sophocarpidine (CAS 519-02-8) Sales Volume Share by Region (2018-2023)

    • Figure China Sophocarpidine (CAS 519-02-8) Sales Volume Share by Region (2018-2023)

    • Table China Sophocarpidine (CAS 519-02-8) Sales Value by Region (2018-2023)

    • Table China Sophocarpidine (CAS 519-02-8) Sales Value Share by Region (2018-2023)

    • Figure China Sophocarpidine (CAS 519-02-8) Sales Value Share by Region (2018-2023)

    • Table North China Sophocarpidine (CAS 519-02-8) Production Volume by Type (2018-2023)

    • Table North China Sophocarpidine (CAS 519-02-8) Production Volume Share by Type (2018-2023)

    • Figure North China Sophocarpidine (CAS 519-02-8) Production Volume Share by Type (2018-2023)

    • Table North China Sophocarpidine (CAS 519-02-8) Sales Volume by Application (2018-2023)

    • Table North China Sophocarpidine (CAS 519-02-8) Sales Volume Share by Application (2018-2023)

    • Figure North China Sophocarpidine (CAS 519-02-8) Sales Volume Share by Application (2018-2023)

    • Table Central China Sophocarpidine (CAS 519-02-8) Production Volume by Type (2018-2023)

    • Table Central China Sophocarpidine (CAS 519-02-8) Production Volume Share by Type (2018-2023)

    • Figure Central China Sophocarpidine (CAS 519-02-8) Production Volume Share by Type (2018-2023)

    • Table Central China Sophocarpidine (CAS 519-02-8) Sales Volume by Application (2018-2023)

    • Table Central China Sophocarpidine (CAS 519-02-8) Sales Volume Share by Application (2018-2023)

    • Figure Central China Sophocarpidine (CAS 519-02-8) Sales Volume Share by Application (2018-2023)

    • Table South China Sophocarpidine (CAS 519-02-8) Production Volume by Type (2018-2023)

    • Table South China Sophocarpidine (CAS 519-02-8) Production Volume Share by Type (2018-2023)

    • Figure South China Sophocarpidine (CAS 519-02-8) Production Volume Share by Type (2018-2023)

    • Table South China Sophocarpidine (CAS 519-02-8) Sales Volume by Application (2018-2023)

    • Table South China Sophocarpidine (CAS 519-02-8) Sales Volume Share by Application (2018-2023)

    • Figure South China Sophocarpidine (CAS 519-02-8) Sales Volume Share by Application (2018-2023)

    • Table East China Sophocarpidine (CAS 519-02-8) Production Volume by Type (2018-2023)

    • Table East China Sophocarpidine (CAS 519-02-8) Production Volume Share by Type (2018-2023)

    • Figure East China Sophocarpidine (CAS 519-02-8) Production Volume Share by Type (2018-2023)

    • Table East China Sophocarpidine (CAS 519-02-8) Sales Volume by Application (2018-2023)

    • Table East China Sophocarpidine (CAS 519-02-8) Sales Volume Share by Application (2018-2023)

    • Figure East China Sophocarpidine (CAS 519-02-8) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Sophocarpidine (CAS 519-02-8) Production Volume by Type (2018-2023)

    • Table Northeast China Sophocarpidine (CAS 519-02-8) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Sophocarpidine (CAS 519-02-8) Production Volume Share by Type (2018-2023)

    • Table Northeast China Sophocarpidine (CAS 519-02-8) Sales Volume by Application (2018-2023)

    • Table Northeast China Sophocarpidine (CAS 519-02-8) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Sophocarpidine (CAS 519-02-8) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Sophocarpidine (CAS 519-02-8) Production Volume by Type (2018-2023)

    • Table Southwest China Sophocarpidine (CAS 519-02-8) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Sophocarpidine (CAS 519-02-8) Production Volume Share by Type (2018-2023)

    • Table Southwest China Sophocarpidine (CAS 519-02-8) Sales Volume by Application (2018-2023)

    • Table Southwest China Sophocarpidine (CAS 519-02-8) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Sophocarpidine (CAS 519-02-8) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Sophocarpidine (CAS 519-02-8) Production Volume by Type (2018-2023)

    • Table Northwest China Sophocarpidine (CAS 519-02-8) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Sophocarpidine (CAS 519-02-8) Production Volume Share by Type (2018-2023)

    • Table Northwest China Sophocarpidine (CAS 519-02-8) Sales Volume by Application (2018-2023)

    • Table Northwest China Sophocarpidine (CAS 519-02-8) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Sophocarpidine (CAS 519-02-8) Sales Volume Share by Application (2018-2023)

    • Table Qinghai Lake Pharmaceuticals Company Profile

    • Table Qinghai Lake Pharmaceuticals Sophocarpidine (CAS 519-02-8) Revenue, Price and Gross (2018-2023)

    • Table Selco Wirkstoffe Vertriebs GmbH Company Profile

    • Table Selco Wirkstoffe Vertriebs GmbH Sophocarpidine (CAS 519-02-8) Revenue, Price and Gross (2018-2023)

    • Table Select Botanical Company Profile

    • Table Select Botanical Sophocarpidine (CAS 519-02-8) Revenue, Price and Gross (2018-2023)

    • Table Jiangsu Tiansheng Pharmaceutical Company Profile

    • Table Jiangsu Tiansheng Pharmaceutical Sophocarpidine (CAS 519-02-8) Revenue, Price and Gross (2018-2023)

    • Table Indena Company Profile

    • Table Indena Sophocarpidine (CAS 519-02-8) Revenue, Price and Gross (2018-2023)

    • Table Fujie Pharmaceutical Company Profile

    • Table Fujie Pharmaceutical Sophocarpidine (CAS 519-02-8) Revenue, Price and Gross (2018-2023)

    • Table TIANSHAN Pharmaceuticals Company Profile

    • Table TIANSHAN Pharmaceuticals Sophocarpidine (CAS 519-02-8) Revenue, Price and Gross (2018-2023)

    • Table Tiansheng Pharmaceutical Company Profile

    • Table Tiansheng Pharmaceutical Sophocarpidine (CAS 519-02-8) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US